secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K
Filed at:   2022-05-17T23:59:59+00:00
Accession:  0001104659-22-061927
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pacific Biosciences CCO Peter Fromen resigns effective May 20, 2022
-------------------------------------------------------------------

- Peter Fromen resigns as Chief Commercial Officer to pursue new opportunities, effective May 20, 2022.
- Departure not due to any disagreement with company operations, policies, or practices.
- CEO Christian Henry assumes marketing responsibilities; VP Chris Seipert takes over sales, service, and support.
- Company conducting a search for a permanent Chief Commercial Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000110465922061927/0001104659-22-061927-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000110465922061927/tm2215853d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-061927

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer